Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Berns Paul L
Relationship:  
City:   Middleton
State:   WI
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   7,962,088    

Indirect Shares

   0      
Direct Value   $78,383,915    

Indirect Value

   $0      
Total Shares   7,962,088      
Total Value   $78,383,915      


Xenoport Inc $0 Jazz Pharmaceuticals Inc $905,848 Cellectar Bioscienc $73,169 Unity Biotechnology Inc $5,055 Neumora Therapeutics, Inc. $77,399,843 Xenoport Inc $0 Jazz Pharmaceuticals Inc $905,848 Cellectar Bioscienc $73,169 Unity Biotechnology Inc $5,055 Neumora Therapeutics, Inc. $77,399,843
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   1.0   
     Percentage Gain/Loss :
     0.0%
 29.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Allos Therapeutics Inc ALTH Chief Executive Officer 2012-09-04 0 0    Premium*  
            Xenoport Inc XNPT Director 2016-05-17 15,000 2008-06-16 0    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2021-08-05 8,290 2011-01-11 0    Premium*  
            Cellectar Bioscienc CLRB Director 2016-04-20 117,371 2016-04-20 0    Premium*  
            Unity Biotechnology Inc UBX Director 2018-05-07 3,261 2018-05-07 0    Premium*  
            EQRx, Inc. EQRX Director 2023-11-09 0 2021-12-17 0    Premium*  
            Neumora Therapeutics, Inc. NMRA 2024-02-14 7,818,166 0    Premium*  
* Premium Members only  

Records found :    73         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EQRX EQRx, Inc. Director   –       •      –    2021-12-17 4 A $0.00 $0 D/D 627,000 627,000 0 -
EQRX EQRx, Inc. Director   –       •      –    2023-11-09 4 D $0.00 $0 D/D (627,000) 0 0 -
NMRA Neumora Therapeutics, Inc...   •       •      –    2024-02-14 4 A $0.00 $0 D/D 171,250 7,818,166 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2011-11-16 4 AS $1.43 $644 D/D (450) 715,962 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2011-11-15 4 AS $1.46 $46,532 D/D (31,817) 716,412 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2012-03-01 4 AS $1.48 $31,816 D/D (21,532) 1,233,323 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2012-02-29 4 AS $1.52 $32,235 D/D (21,163) 1,254,855 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2012-02-24 4 AS $1.55 $6,743 D/D (4,350) 702,512 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2012-02-23 4 AS $1.56 $14,196 D/D (9,100) 706,862 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       •      –    2012-09-04 4 D $1.82 $2,244,648 D/D (1,233,323) 0 0 -
CLRB Cellectar Bioscienc Director   –       •      –    2016-04-20 4 B $2.12 $248,827 D/D 117,371 117,371 2.39 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2006-04-13 4 B $2.94 $14,700 D/D 5,000 305,000 2.74 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2006-12-29 4 B $3.05 $7,629 D/D 2,500 307,500 2.74 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2011-02-24 4 AS $3.12 $13,293 D/D (4,255) 399,787 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2009-08-05 4 OE $3.14 $25,120 D/D 8,000 239,907 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2009-08-10 4 OE $3.14 $1,073,880 D/D 342,000 573,907 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2011-03-17 4 OE $3.14 $7,850 D/D 2,500 748,229 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2011-02-23 4 AS $3.25 $29,878 D/D (9,193) 404,042 0 -
XNPT Xenoport Inc Director   –       •      –    2014-05-15 4 AS $3.66 $9,150 D/D (2,500) 5,000 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2007-12-31 4 B $3.89 $19,465 D/D 5,000 288,875 2.74 -
XNPT Xenoport Inc Director   –       •      –    2014-04-24 4 AS $4.30 $10,750 D/D (2,500) 2,500 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2008-03-10 4 AS $5.19 $185,125 D/D (34,400) 254,475 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2007-03-12 4 AS $6.45 $152,466 D/D (23,625) 283,875 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2009-03-10 4 D $6.54 $224,000 D/D (34,235) 231,907 0 -
ALTH Allos Therapeutics Inc Chief Executive Officer   •       –      –    2010-01-08 4 AS $7.00 $456,120 D/D (65,160) 166,747 0 -
  73  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us